Resultats de la cerca - Pascal Claudepierre
- Mostrar 1 - 20 resultats de 22
- Anar a la pàgina següent
-
1
-
2
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study per Laura Pina Vegas, Philippe Le Corvoisier, Laëtitia Penso, Muriel Paul, É. Sbidian, Pascal Claudepierre
Publicat 2021Artigo -
3
Performances of the Assessment of SpondyloArthritis International Society Axial Spondyloarthritis Criteria for Diagnostic and Classification Purposes in Patients Visiting a Rheumat... per Anna Moltó, S. Paternotte, D. Comet, E. Thibout, Martín Rudwaleit, Pascal Claudepierre, Désirée van der Heijde, Maxime Dougados
Publicat 2013Artigo -
4
Differences Between Women and Men With Recent‐Onset Axial Spondyloarthritis: Results From a Prospective Multicenter French Cohort per Anne Tournadre, Bruno Pereira, A. Lhoste, Jean‐Jacques Dubost, Jean-Michel Ristori, Pascal Claudepierre, Maxime Dougados, Martin Soubrier
Publicat 2013Artigo -
5
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis per Martín Rudwaleit, Pascal Claudepierre, P Wordsworth, Eduardo Loza Cortina, Joachim Sieper, Martina Kron, Roberto Carcereri-De-Prati, H. Küpper, S. Kary
Publicat 2009Artigo -
6
Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis per Daniel Wendling, Cédric Lukas, Julien Paccou, Pascal Claudepierre, Laurence Carton, Bernard Combe, Philippe Goupille, Françis Guillemin, Christophe Hudry, Corinne Miceli‐Richard, Maxime Dougados
Publicat 2014Artigo -
7
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA) per Maxime Dougados, J. Lucas y Hernandez, E. Desfleurs, Pascal Claudepierre, Philippe Goupille, Adeline Ruyssen‐Witrand, Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas
Publicat 2023Artigo -
8
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases per C. Daïen, Alban Le Monnier, Pascal Claudepierre, A. Constantin, JP Eschard, Éric Houvenagel, M. Samimi, Stéphan Pavy, Édouard Pertuiset, Éric Toussirot, Bernard Combe, Jacques Morel
Publicat 2009Revisão -
9
Rate and Predisposing Factors for Sacroiliac Joint Radiographic Progression After a Two‐Year Follow‐up Period in Recent‐Onset Spondyloarthritis per Maxime Dougados, Christophe Dematteï, Rosaline van den Berg, V. Vo Hoang, F. Thévenin, M. Reijnierse, Damien Lœuille, A. Feydy, Pascal Claudepierre, Désirée van der Heijde
Publicat 2016Artigo -
10
Spinal Radiographic Progression in Early Axial Spondyloarthritis: Five‐Year Results From the <scp>DESIR</scp> Cohort per Sofía Ramiro, Désirée van der Heijde, Alexandre Sepriano, M. van Lunteren, Anna Moltó, A. Feydy, Maria Antonietta D’Agostino, Damien Lœuille, Maxime Dougados, M. Reijnierse, Pascal Claudepierre
Publicat 2018Artigo -
11
Ten-year follow-up of degenerative spinal lesions on radiographs and MRI in axial spondyloarthritis: results of the DESIR (DEvenir des spondylarthropathies indifférenciées récentes... per Laura Pina Vegas, M. van Lunteren, Damien Lœuille, C. Morizot, E.C. Newsum, Sofia Ramiro, F. van Gaalen, Alain Saraux, Pascal Claudepierre, A. Feydy, Désirée van der Heijde, M. Reijnierse
Publicat 2025Artigo -
12
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database per Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, Anissa Zarour, Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian
Publicat 2022Artigo -
13
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR... per Maxime Dougados, Walter P. Maksymowych, Robert Landewé, Anna Moltó, Pascal Claudepierre, Manouk de Hooge, R. Lambert, R. Bonin, Jack F. Bukowski, Heather Jones, I. Logeart, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Désirée van der Heijde
Publicat 2017Artigo -
14
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis per Daniel Wendling, Sophie Hecquet, O. Fogel, Jean-Guillaume Letarouilly, Frank Verhoeven, Thao Pham, Clément Prati, Anna Moltó, Philippe Goupille, Emmanuelle Dernis, Alain Saraux, Adeline Ruyssen‐Witrand, Cédric Lukas, Corinne Miceli‐Richard, Christophe Hudry, Pascal Richette, Maxime Bréban, Laure Gossec, Maxime Dougados, Pascal Claudepierre
Publicat 2022Revisão -
15
Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment per Maxime Bréban, Philippe Ravaud, Pascal Claudepierre, Gabriel Baron, Yves‐Dominique Henry, Christophe Hudry, Liana Euller‐Ziegler, Thao Pham, Elisabeth Solau‐Gervais, Isabelle Chary‐Valckenaere, Christian Marcelli, Aleth Perdriger, Xavier Le Loët, Daniel Wendling, Bruno Fautrel, B Fournié, B. Combe, Philippe Gaudin, Sandrine Jousse, Xavier Mariette, A. Baleydier, Gérard Trape, Maxime Dougados
Publicat 2007Artigo -
16
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial per Anna Moltó, Clementina López‐Medina, Filip Van den Bosch, Annelies Boonen, Casper Webers, E. Dernis, F. van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, Mirian Starmans‐Kool, Anneke Spoorenberg, Peggy Jacques, Philippe Carron, Rik Joos, Jan Lenaerts, Laure Gossec, Sophie Pouplin, Adeline Ruyssen‐Witrand, L. Sparsa, Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados
Publicat 2021Artigo -
17
Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants per Hélène Bauer, Cécile Luxembourger, Jacques‐Eric Gottenberg, Sophie Fournier, Florence Abravanel, Alain Cantagrel, Emmanuel Chatelus, Pascal Claudepierre, Christophe Hudry, Jacques Izopet, Sylvie Fabre, Guillaume Lefèvre, Laurent Marguerie, Antoine Martin, Laurent Messer, Anna Moltó, Béatrice Pallot-Pradès, Yves‐Marie Pers, Anne‐Marie Roque‐Afonso, C. Roux, Christelle Sordet, Martin Soubrier, Claire Veissier, Daniel Wendling, Jean‐Marie Péron, Jean Sibilia
Publicat 2015Artigo -
18
Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug per Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger, S Lassoued, Jean-Marie Berthelot, Daniel Wendling, Liana Euller‐Ziegler, Martin Soubrier, Christophe Richez, Bruno Fautrel, Arnaud Constantin, Xavier Mariette, Jacques Morel, Mélanie Gilson, Grégoire Cormier, Jean Hugues Salmon, S. Rist, Frédéric Lioté, Hubert Marotte, Christine Bonnet, Christian Marcelli, Jérémie Sellam, Olivier Meyer, Elisabeth Solau‐Gervais, Sandrine Guis, Jean‐Marc Ziza, Charles Zarnitsky, Isabelle Chary-Valckenaere, Olivier Vittecoq, Alain Saraux, Yves‐Marie Pers, M. Gayraud, G Bolla, Pascal Claudepierre, M. Ardizzone, Emmanuelle Dernis, Maxime Bréban, Olivier Fain, Jean-Charles Balblanc, Ouafaa Aberkane, Marion Vazel, Christelle Back, Sophie Candon, Lucienne Chatenoud, Élodie Perrodeau, Jean Sibilia, Philippe Ravaud
Publicat 2016Artigo -
19
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update per Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf‐Henning Boehncke, Bente Appel Esbensen, Iain B. McInnes, Dennis McGonagle, Kevin Winthrop, Andra Bălănescu, P Bálint, Gerd R Burmester, Juan D. Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, Annamaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiró, Daniele Mauro, Helena Marzo‐Ortega, Philip J. Mease, Peter Nash, Wendy Wagenaar, L. Savage, Georg Schett, Stephanie Shoop-Worrall, Yoshiya Tanaka, Filip Van den Bosch, Annette H M van der Helm–van Mil, Alen Zabotti, Désirée van der Heijde, Josef S Smolen
Publicat 2024Revisão -
20
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients per Florence A. Aeschlimann, Nassim Ait-Abdallah, Jean-David Albert, Didier Alcais, Yannick Allanore, Blanca Amador-Borreiro, Zahir Amoura, Emma André, Jean‐Benoît Arlet, Laurent Arnaud, Denis Arniaud, Herliette Arty-Hue, Lucie Atlan, Christine Audoin-Pajot, Victor Audren, Jérôme Avouac, Maxime Bach-Bunner, Hélène Bacquet-Deschryver, Brigitte Bader‐Meunier, Nathalie Balandraud, Jean‐Charles Balblanc, Stéphane Bally, F. Banal, Béatrice Banneville, Thomas Barnetche, A. Barrelet, A. Basch, Vincent Baumier, Guillaume Bayer, S. Bayle, Véronique D. Belin, Rakiba Belkhir, Ruben Benaïnous, Alexandre Bélot, Mohamed Ben Ammar, Mathilde Benhamou, Y. Benhamou, Ahmed Benmansour, Pascal Bennet, Brigitte Bernoux-Manat, E. Berthoux, Ewa Bertolini, Aurélia Bisson-Vaivre, Thomas Gille, G Bolla, Olivier Bonidan, Christine Bonnet, Raphaël Borie, Laurence Boudou, Françoise Bouhour, Kévin Bouiller, B. Bouldoires, Karima Boussoualim, Éric Bouvard, Regine Brondino, P. Buchlin, P. Cacoub, Maurizio Carteni, Aurélia Carbasse, Brice Castel, P. Cathébras, Hervé Caumont, Annalisa Celant, Benjamin Chaigne, Benoît Chaillous, Romuald Champy, Agnès Charcot, Pierre Charles, Isabelle Charlot-Lambrecht, Emmanuel Chatelus, B. Chaudier, Pascal Chazerain, P Chertok, Xavier Chevalier, Maxime Chevreau, Emilie Chotard, Lin Chu Miow, Pascal Claudepierre, Gaëlle Clavel, Cyril Clavel-Osorio, Fleur Cohen, Gregory H. Cohen, Marie-Eve Colette-Cedoz, Nived Collercandy, Antoine Colombey, C. Comarmond, Bernard Combe, Céline Comparon, Élodie Constant, Clémence Corre, N. Costedoat‐Chalumeau, Marie Couret, Natacha Courvoisier, Fabienne Coury, Cécile Coutarel, F. Coutier, R. Damade, Laurence Daver-Malaterre, Sarahe Dehimat, Michel Delahousse
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Cohort
Psoriatic arthritis
Ankylosing spondylitis
Rheumatoid arthritis
Sacroiliitis
Axial spondyloarthritis
Physical therapy
Surgery
Arthritis
Tumor necrosis factor alpha
Infliximab
Radiology
Randomized controlled trial
Adalimumab
Adverse effect
Alternative medicine
Confidence interval
Dermatology
Discontinuation
Disease
Etanercept
Immunology
Magnetic resonance imaging
Pathology
Psoriasis
Radiography
Spondylitis
BASDAI